Antibody Drug Conjugates Market Trend Analysis Highlighting Rapid Expansion to US$ 38,077.45 Million by 2031
The antibody drug conjugates (ADC) market is emerging as one of the most promising segments within oncology therapeutics, driven by the growing need for targeted cancer treatments. ADCs combine monoclonal antibodies with potent cytotoxic drugs, enabling precise delivery of chemotherapy directly to cancer cells while minimizing damage to healthy tissues. This targeted approach has significantly...
0 التعليقات 0 المشاركات 120 مشاهدة 0 معاينة
إعلان مُمول
MyLiveRoom https://myliveroom.com